Suzuken Co. Ltd.
https://www.suzuken.co.jp/en/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Suzuken Co. Ltd.
Dainippon, SanBio Call Time On Stroke Cell Therapy Alliance
Japanese companies agree to discontinue regenerative cell therapy pact after high-profile Phase II failure, but SanBio will move ahead with development and Dainippon will hold onto ex-partner stake for now.
Warning Letter Roundup & Recap
SmartMonitor battery pack troubles dog Philips Children’s Medical Ventures; maker of GenStrip glucose test strips cited for QS and MDR reg violations; the Portable Exchange Deionization System was labeled to meet the requirements of an outdated ANSI/AAMI standard. Nine quality-related warning letters were listed by FDA from Aug. 12 through Sept. 11.
How Drugs Are Distributed In Japan: Insider Analysis From International Alliances Ltd.’s Reed Maurer
A closer look at components of Japan’s distribution system reveals a vastly improved network than previous years.
Pfizer And Mylan Team Up For Generics Opportunity In Japan
As the Japanese government tries to boost generics utilization, Pfizer and Mylan plan to leverage combined strengths to become a market leader by 2015.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Consumables, Central Supplies
- Diagnostic Equipment & Supplies
- Diagnostic Imaging Equipment & Supplies
- Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- Suzuken Group
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice